PT99720A - Processo para a preparacao de novas composicoes farmaceuticas contendo uma substancia ionizavel com actividade farmacologica - Google Patents

Processo para a preparacao de novas composicoes farmaceuticas contendo uma substancia ionizavel com actividade farmacologica

Info

Publication number
PT99720A
PT99720A PT99720A PT9972091A PT99720A PT 99720 A PT99720 A PT 99720A PT 99720 A PT99720 A PT 99720A PT 9972091 A PT9972091 A PT 9972091A PT 99720 A PT99720 A PT 99720A
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
compositions containing
pharmacological activity
new pharmaceutical
preparing new
Prior art date
Application number
PT99720A
Other languages
English (en)
Other versions
PT99720B (pt
Inventor
Bengt Magnus Lindstedt
Per Johan Gunnar Lundberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PT99720A publication Critical patent/PT99720A/pt
Publication of PT99720B publication Critical patent/PT99720B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
PT99720A 1990-12-07 1991-12-06 Processo para a preparacao de novas composicoes farmaceuticas contendo uma substancia ionizavel com actividade farmacologica PT99720B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003903A SE9003903D0 (sv) 1990-12-07 1990-12-07 New pharmaceutical formulations

Publications (2)

Publication Number Publication Date
PT99720A true PT99720A (pt) 1992-10-30
PT99720B PT99720B (pt) 2002-04-29

Family

ID=20381122

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99720A PT99720B (pt) 1990-12-07 1991-12-06 Processo para a preparacao de novas composicoes farmaceuticas contendo uma substancia ionizavel com actividade farmacologica

Country Status (17)

Country Link
US (2) US5707656A (pt)
EP (1) EP0560816B1 (pt)
JP (1) JP3276956B2 (pt)
AT (1) ATE444737T1 (pt)
AU (1) AU656346B2 (pt)
CA (1) CA2097176C (pt)
DE (1) DE69133623D1 (pt)
EE (1) EE03105B1 (pt)
FI (1) FI932553L (pt)
HU (1) HU218661B (pt)
IE (1) IE914136A1 (pt)
IS (1) IS1749B (pt)
NO (1) NO305536B1 (pt)
PT (1) PT99720B (pt)
SE (1) SE9003903D0 (pt)
WO (1) WO1992010171A1 (pt)
YU (1) YU186791A (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU736308B2 (en) * 1996-12-20 2001-07-26 Warner-Lambert Company Llc Antitussive drugs delivered by ion exchange resins
US20030118641A1 (en) * 2000-07-27 2003-06-26 Roxane Laboratories, Inc. Abuse-resistant sustained-release opioid formulation
EP1204406A2 (en) * 1999-07-29 2002-05-15 Roxane Laboratories, Inc. Opioid sustained-released formulation
KR20030034171A (ko) * 2001-07-06 2003-05-01 엔도 파마슈티걸즈, 인크. 옥시모르폰 제어 방출 제형
US20030099711A1 (en) * 2001-08-29 2003-05-29 David Meadows Sustained release preparations
AU2003230805A1 (en) * 2002-04-05 2003-10-27 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
JP2006296511A (ja) * 2005-04-15 2006-11-02 Transcutaneous Technologies Inc 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ
JP2006346368A (ja) * 2005-06-20 2006-12-28 Transcutaneous Technologies Inc イオントフォレーシス装置及びその製造方法
EP1905433A1 (en) * 2005-07-15 2008-04-02 Transcu Ltd. Percutaneous absorption patch with application position indicating function, and iontophoresis device
JP2007037868A (ja) * 2005-08-05 2007-02-15 Transcutaneous Technologies Inc 経皮投与装置及びその制御方法
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US20070060860A1 (en) * 2005-08-18 2007-03-15 Transcutaneous Technologies Inc. Iontophoresis device
JPWO2007026671A1 (ja) * 2005-08-29 2009-03-05 Ｔｔｉ・エルビュー株式会社 センサからの情報により投与すべき薬剤の選定を行うイオントフォレーシス装置
BRPI0616166A2 (pt) * 2005-09-16 2011-06-07 Tti Ellebeau Inc dispositivo de iontoforese do tipo de cateter
US20070073212A1 (en) * 2005-09-28 2007-03-29 Takehiko Matsumura Iontophoresis apparatus and method to deliver active agents to biological interfaces
US20070071807A1 (en) * 2005-09-28 2007-03-29 Hidero Akiyama Capsule-type drug-releasing device and capsule-type drug-releasing device system
US20090299265A1 (en) * 2005-09-30 2009-12-03 Tti Ellebeau, Inc. Electrode Assembly for Iontophoresis Having Shape-Memory Separator and Iontophoresis Device Using the Same
JPWO2007037476A1 (ja) * 2005-09-30 2009-04-16 Ｔｔｉ・エルビュー株式会社 睡眠導入剤と興奮剤の投与量および投与時期を制御するイオントフォレーシス装置
US20070093787A1 (en) * 2005-09-30 2007-04-26 Transcutaneous Technologies Inc. Iontophoresis device to deliver multiple active agents to biological interfaces
US20070197955A1 (en) * 2005-10-12 2007-08-23 Transcutaneous Technologies Inc. Mucous membrane adhesion-type iontophoresis device
US20080193514A1 (en) * 2006-11-02 2008-08-14 Transcu Ltd. Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
WO2008087803A1 (ja) * 2007-01-16 2008-07-24 Hokkaido University 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤
JP2010187707A (ja) * 2007-06-12 2010-09-02 Hokkaido Univ インスリンを封入したイオントフォレーシス用リポソーム製剤
JP2012501801A (ja) * 2008-09-10 2012-01-26 トランスキュー リミテッド ヒドロキシプロピルセルロース（ｈｐｃ）をベースにした粘性液体を多孔質基材に薬剤投与する装置および方法、例えば連続ウェブをベースにしたプロセス
WO2010115015A1 (en) * 2009-04-03 2010-10-07 Coating Place, Inc. Modified-release pharmaceutical drug composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983392A (en) * 1983-11-14 1991-01-08 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
EP0199855A1 (en) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Tablets comprising tromethoprim and a sulfonamide
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
IE62100B1 (en) * 1986-07-30 1994-12-14 Fisons Corp Coated ion exchange resins
DE3740684A1 (de) * 1987-12-01 1989-06-15 Woehr Otto Gmbh Parksystem
MC2025A1 (fr) * 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof

Also Published As

Publication number Publication date
FI932553A0 (fi) 1993-06-04
SE9003903D0 (sv) 1990-12-07
AU8930591A (en) 1992-07-08
PT99720B (pt) 2002-04-29
IS1749B (is) 2000-07-11
IE914136A1 (en) 1992-06-17
NO932053D0 (no) 1993-06-04
HU218661B (hu) 2000-10-28
EP0560816B1 (en) 2009-10-07
CA2097176A1 (en) 1992-06-08
FI932553A7 (fi) 1993-06-04
FI932553L (fi) 1993-06-04
ATE444737T1 (de) 2009-10-15
DE69133623D1 (de) 2009-11-19
IS3787A7 (is) 1992-06-08
EE03105B1 (et) 1998-08-17
CA2097176C (en) 2002-03-26
HU9301671D0 (en) 1993-09-28
NO932053L (no) 1993-07-20
EP0560816A1 (en) 1993-09-22
JPH06503311A (ja) 1994-04-14
YU186791A (sh) 1994-04-05
JP3276956B2 (ja) 2002-04-22
WO1992010171A1 (en) 1992-06-25
US5707656A (en) 1998-01-13
NO305536B1 (no) 1999-06-21
US5709882A (en) 1998-01-20
HUT64213A (en) 1993-12-28
AU656346B2 (en) 1995-02-02

Similar Documents

Publication Publication Date Title
SE9003903D0 (sv) New pharmaceutical formulations
ATA86885A (de) Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge
YU174490A (sh) Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja
ES2115231T3 (es) Emplasto con sustancias activas.
KR880001288A (ko) 경구투여 형태의 서방성 약제학적 조성물
ES2085337T3 (es) Comprimidos farmaceuticos.
ES2081384T3 (es) Preparado farmaceutico que contiene complejos de polielectrolitos en forma de microparticulas y por lo menos una sustancia activa.
GEP20012580B (en) Substituted 4-Hydroxy-Phenylalcanoic Acid Derivatives With Agonist Activity to PPAR-Gamma, Methods for Their Production, Pharmaceutical Conposition and Methods for Treatment
ATE330943T1 (de) Herstellungsverfahren von huperzine a und deren analogen und verbindungen nützlich dazu
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
ES510245A0 (es) "un metodo para obtener una preparacion de insulina".
DE3870801D1 (de) Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten.
ES2029853T3 (es) Un metodo para preparar una base para pomada de gel.
BR0009927A (pt) Método para produzir uma matriz de liberação controlada, amórfica ou parcialmente amórfica insolúvel em água
DK0957981T3 (da) Rersorvoirer til aflevering af lægemidler ved elektrotransport, indeholdende inerte fyldmaterialer
ES2054177T3 (es) Derivados disubstituidos del acido (quinolin-2-il-metoxi)fenilacetico.
ES2043696T3 (es) Derivados de prostaglandina e1 (derivados-pge1) como substancias activas farmaceuticas y medicamentos que contienen estos compuestos, especialmente para aplicacion transcutanea.
ES2007328A4 (es) Derivados de dihidropiridazinona, proceso de fabricacion y medicamentos con sus combinaciones
PT87737A (pt) Processo para a preparacao de composicoes farmaceuticas analgesicas contendo derivados de dioxopiperidina como substancia activa
SE9803272D0 (sv) A drug for cell regeneration
ES534859A0 (es) Procedimiento para la obtencion de derivados de 1-(4'-alquilsulfonilfenil)-2-amino-1,3-propandiol n-substituidos
IT1164389B (it) Derivati n-sostituiti dell'1-(4'-alchiltiofenil)-2-ammino-1,3-propandiolo
ES469749A1 (es) Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.
ES2043896T3 (es) Procedimiento para la preparacion de derivados de tetrahidropiridina.
BR8904653A (pt) Processo para a producao de um baculovirus hibrido,bem como composicao inseticida

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920617

FG3A Patent granted, date of granting

Effective date: 20020115